G. Vlahos

发表

Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents

M. Dimopoulos, D. Haidopoulos, C. Bamia, 2012, Oncology.

Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.

M. Dimopoulos, O. Tsitsilonis, E. Terpos, 2008, Gynecologic oncology.

Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.

M. Dimopoulos, O. Tsitsilonis, A. Bamias, 2007, Gynecologic oncology.

A Risk-Adapted Strategy of Adjuvant Paclitaxel/Carboplatin in Early-Stage Ovarian Cancer: Time-Dependent Effect of 4 versus 6 Cycles on Outcome

M. Dimopoulos, D. Haidopoulos, C. Bamia, 2012, Oncology.

Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum‐paclitaxel chemotherapy

T. Psaltopoulou, D. Haidopoulos, C. Papadimitriou, 2010, Cancer.

Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor.

M. Dimopoulos, D. Haidopoulos, A. Bamias, 2012, European journal of cancer.

VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2

M. Dimopoulos, O. Tsitsilonis, D. Haidopoulos, 2012, International journal of cancer.

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

M. Dimopoulos, A. Ziogas, O. Tsitsilonis, 2012, British Journal of Cancer.

Passive–active immunoprophylaxis for all infants born from HBeAG‐negative chronic HBV‐infected mothers: Is it a cost‐effective strategy?

I. Elefsiniotis, A. Antsaklis, G. Vlahos, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Intrauterine-transplacental transmission of hepatitis B virus (HBV) from hepatitis B e antigen negative (precore mutant, G1896A) chronic HBV infected mothers to their infants. Preliminary results of a prospective study.

C. Barbatis, A. Antsaklis, G. Daskalakis, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Clinical Significance of Hepatitis B Surface Antigen in Cord Blood of Hepatitis B e-Antigen-Negative Chronic Hepatitis B Virus-Infected Mothers

A. Antsaklis, G. Daskalakis, I. Elefsiniotis, 2009, Intervirology.

Paclitaxel- and Platinum-Based Postoperative Chemotherapy for Primary Fallopian Tube Carcinoma: A Single Institution Experience

M. Dimopoulos, A. Bamias, C. Papadimitriou, 2008, Oncology.

Young Age Is Associated with Favorable Characteristics but Is Not an Independent Prognostic Factor in Patients with Epithelial Ovarian Cancer: A Single Institution Experience

M. Dimopoulos, E. Kastritis, C. Papadimitriou, 2006, Oncology.

The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy.

E. Kastritis, A. Bamias, C. Papadimitriou, 2007, Gynecologic oncology.

Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome.

M. Dimopoulos, E. Kastritis, A. Bamias, 2007, Anticancer research.

Prognostic value of preoperative Ca125 and Tag72 serum levels and their correlation to disease relapse and survival in endometrial cancer

G. Vorgias, A. Rodolakis, G. Vlahos, 2015, Archives of Gynecology and Obstetrics.